(Q37151302)

18 August 2017

1 reference

title

Preventing HIV antiretroviral resistance through better monitoring of treatment adherence (English)

1 reference

18 August 2017

0 references

anti-retroviral agent

0 references

1 reference

1

David R Bangsberg

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Journal of Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

197 Suppl 3

1 reference

18 August 2017

page(s)

S272-8

1 reference

When should we delay highly active antiretroviral therapy?

18 August 2017

cites work

1 reference

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

21 January 2018

1 reference

Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?

21 January 2018

1 reference

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials

21 January 2018

1 reference

Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors

21 January 2018

1 reference

Telemonitoring for patients with chronic heart failure: a systematic review

21 January 2018

1 reference

Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004.

21 January 2018

1 reference

A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

21 January 2018

1 reference

A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy

21 January 2018

1 reference

A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment

21 January 2018

1 reference

Modified directly observed therapy for treatment of human immunodeficiency virus

21 January 2018

1 reference

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups

21 January 2018

1 reference

Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial

21 January 2018

1 reference

Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment

21 January 2018

1 reference

How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

21 January 2018

1 reference

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

21 January 2018

1 reference

A randomized trial of directly administered antiretroviral therapy and adherence case management intervention

21 January 2018

1 reference

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

21 January 2018

1 reference

Adherence communication: a qualitative analysis of physician-patient dialogue

21 January 2018

1 reference

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

21 January 2018

1 reference

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

21 January 2018

1 reference

Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale

21 January 2018

1 reference

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial

21 January 2018

1 reference

Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy

21 January 2018

1 reference

The assessment of refill compliance using pharmacy records: methods, validity, and applications

21 January 2018

1 reference

Medication refill logistics and refill adherence in HIV.

21 January 2018

1 reference

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

21 January 2018

1 reference

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

21 January 2018

1 reference

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

21 January 2018

1 reference

Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone

21 January 2018

1 reference

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

21 January 2018

1 reference

Overconsumption detected by electronic drug monitoring requires subtle interpretation

21 January 2018

1 reference

A prospective study of predictors of adherence to combination antiretroviral medication

21 January 2018

1 reference

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis

21 January 2018

1 reference

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

21 January 2018

1 reference

Adherence-resistance relationships to combination HIV antiretroviral therapy

21 January 2018

1 reference

Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen

21 January 2018

1 reference

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

21 January 2018

1 reference

Selective drug taking during combination antiretroviral therapy in an unselected clinic population.

21 January 2018

1 reference

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

21 January 2018

1 reference

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression

21 January 2018

1 reference

Should pharmacogenomic studies be required for new drug approval?

21 January 2018

1 reference

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

21 January 2018

1 reference

A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression

21 January 2018

1 reference

The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone

21 January 2018

1 reference

Home Visits to Improve Adherence to Highly Active Antiretroviral Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/533415

1 reference

18 August 2017

1 reference